Another miRNA involved in the response to cisplatin is miR-199a-3p, which is expressed at low levels in BC cells lines resistant to cisplatin; but when overexpressed, it increased the sensitivity to cisplatin thorough targeting TFAM (mitochondrial transcription factor A), an important protein for maintaining mitochondrial biogenesis. The gene discussed is TFAM; the disease is breast cancer.